ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 26074 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 26074; 2) Community: the network communities that were significantly associated with the response to NSC 26074; 3) Molecule: the relationships between components within communities and NSC 26074; 4) MDR: the compounds that were significantly associated with the NSC 26074.

NSC Compound Enrichment Correlation
NSC 710334 Null 0.0446159312763235 0.47828461
NSC 722316 Null 0.0446159312763235 0.0073715327
NSC 737613 Null 0.0446159312763235 0.22202483
NSC 740602 Null 0.0446159312763235 0.39150811
NSC 763646 (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole 0.0446159312763235 0.37041494
NSC 79563 1,3-bis(4-chlorobenzyl)-2-(phenanthren-9-yl)hexahydropyrimidine 0.0446159312763235 0.36512406
NSC 625498 4-Morpholinecarbodithioic acid, antimony complex 0.0459335986102862 0.099414279
NSC 630375 2H-1-Benzopyran-2-one, 4-(2-benzofuranyl)-7-methoxy- 0.0459335986102862 -0.25485728
NSC 632790 Platinum, dichloro(quinoline-N)[sulfinylbis(methane)-S]-, (SP-4-1) 0.0459335986102862 0.4012904
NSC 641111 Null 0.0459335986102862 0.10385521
Total:90  Current:80    [First] [Prev] [Next] [Last]